The exact record behind the name
The DailyMed Synthroid record identifies AbbVie’s levothyroxine sodium tablets for oral use. The record we checked on September 27, 2026 was updated February 20, 2024, with prescribing information revised February 2024. An access date tells you when we looked; it is not a claim that the label was newly revised that day.
The label includes thyroid hormone replacement uses and a separate role in certain thyroid cancer treatment. Those indications should not be collapsed into a general energy, metabolism or wellness benefit. The clinical purpose of a prescription depends on the person’s diagnosis. A manufacturer’s product record is evidence about the medicine, not proof that a reader needs it.
Ingredient detail is more useful than a purity impression
The label’s description lists inactive ingredients including acacia, confectioner’s sugar containing corn starch, lactose monohydrate, magnesium stearate, povidone and talc. Color additives vary by strength. An ingredient question therefore needs the exact prescribed tablet, not only the brand name. The source also says its ingredients are not made from wheat, barley or rye. Product description.
That statement should not become a promise that everyone with an allergy or digestive condition will tolerate the product. The same labeling discusses reactions to inactive ingredients. A pharmacist can check the formulation against a specific concern. Our Tirosint capsule review provides another formulation record without treating a shorter ingredient list as a universal advantage.
Popularity is not comparative clinical evidence
The manufacturer homepage promotes Synthroid’s prescribing popularity and presents patient stories. Its popularity claim carries a historical measurement period; it is not a current head-to-head study proving better symptom control. A testimonial can describe a person’s reported experience, but it cannot tell how another patient would have done with an alternative.
For that reason, we do not turn stories, prescribing volume or the word “consistent” into a clinical score. A comparative assertion needs a named comparator, relevant patients, defined outcomes and an appropriate study design. Our review-quality guide helps distinguish those requirements from advertising that may be accurate within a narrower scope.
What the brand-versus-generic question can support
The FDA’s generic-drug standards require an approved generic counterpart to meet defined sameness, bioequivalence and quality requirements. The agency states that approved generics provide the same clinical benefits and risks as their brand-name counterparts. This is a reason not to assume that a familiar brand is inherently more effective than an approved generic.
It is also not a direction to make an unsupervised formulation change. The FDA’s levothyroxine research summary describes retrospective evidence about generic-to-generic switching, with limitations; it is not a Synthroid-versus-every-alternative trial. Keep product identity and clinical follow-up visible. The offers comparison explains why selecting care and selecting a branded product are different decisions.
The important safety information is part of the review
Synthroid’s boxed warning states that thyroid hormone is not a treatment for obesity or weight loss. The full label also addresses risks of excessive or inadequate treatment, including cardiac concerns and bone effects from over-replacement. These points are essential to the product record even when a person is mainly comparing price or tablet ingredients. Prescribing information.
This review does not provide a dose, a personal laboratory target or instructions for changing treatment. Ask the prescribing clinician and pharmacist to review the actual medicine list, supplement use and administration instructions. A thyroid brand does not remove the need to consider interactions, individual circumstances or the reason symptoms have changed.
Two savings arrangements should not be blended
The Synthroid support page describes both a copay card and the Synthroid Delivers cash pharmacy program. The card has eligibility restrictions, including exclusions for government-funded prescription reimbursement. The delivery program is a separate arrangement and should not be described as that same card available to everyone.
The delivery program terms list $29.50 for 30 tablets, $54 for 60 and $75 for 90. Those are published quantity prices, not a personal monthly guarantee. The terms say it operates without insurance, costs cannot be submitted for insurance reimbursement, and Medicare Part D participants have additional notice and out-of-pocket accounting conditions. Prescription quantity and eligibility still matter; another pharmacy or insurance route may cost less.
First-order shipping is a distinct benefit
The Synthroid Delivers page advertises free two-day shipping on the first order. Its FAQ describes free standard shipping for orders generally and lists optional expedited charges, including $12 for two-day shipping. The first-order benefit should not be extended to every future refill. Check the current program page and confirm the delivery method and any charge for the particular order; a promotional shipping option is not a guarantee of arrival.
A quoted drug price also does not pay for every part of clinical care. Visits, tests and follow-up are separate questions unless a written arrangement explicitly includes them. Use the quote-components guide to document those costs and confirm the payable amount, delivery method and refill process for the actual prescription.
The conclusion this record permits
Synthroid has identifiable prescription labeling and specific manufacturer access programs. That makes its product identity and published terms reviewable. It does not establish that it is the best medicine for every adult, that a testimonial predicts an outcome, or that one savings route is always cheapest.
If Synthroid is being considered through a prescribing service, ask that service to confirm the exact product independently. Our CoreAge review illustrates the distinction: a page naming levothyroxine does not verify a Synthroid prescription. Keep the label, clinical reason, pharmacy quote and responsible prescriber together when evaluating the offer.